Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
This study XXX - Bifidobacterium animalis lactis BB-12 TM + Fructooligosaccharides (FOS) + Lactobacillus acidophilus LA-5 TM + Lactobacillus delbrueckii bulgaricus LBY-27 + Streptococcus thermophilus STY-31 TM & Ulcerative Colitis (UC) aimed to explore the range of colonic microflora in colitis patients and determine if a month's treatment with synbiotics could modify it (1)
A pilot study evaluating Bifidobacterium animalis lactis BB-12 TM + Fructooligosaccharides (FOS) + Lactobacillus acidophilus LA-5 TM + Lactobacillus delbrueckii bulgaricus LBY-27 + Streptococcus thermophilus STY-31 TM or placebo in 16 (evuated) patients of which 8 had Crohn’s disease (CD) and 8 had ulcerative colitis (UC) in a “crossed over” design (1)